Emerging injectable therapies for multiple sclerosis - The Lancet Neurology
Natalizumab for Multiple Sclerosis | NEJM
Pathophysiology of MS and mechanism of action of natalizumab. | Download Scientific Diagram
Multiple sclerosis and drug discovery: A work of translation - eBioMedicine
Brain Sciences | Free Full-Text | Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
Natalizumab (Tysabri) | American Journal of Neuroradiology
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Natalizumab blocks lymphocyte homing in MS. (A) 4 integrin binds to... | Download Scientific Diagram
Current immunotherapies for multiple sclerosis and neuromyelitis optica spectrum disorders: the similarities and differences
Natalizumab | Nature Reviews Drug Discovery
Currently Approved Disease-Modifying Drugs: Monoclonal Antibody Natalizumab - ScienceDirect
Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project - The Lancet Oncology
Frontiers | Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies | Immunology
Eosinophilia during natalizumab treatment: Incidence, risk factors and temporal patterns - ScienceDirect
Multiple Sclerosis: Mechanisms and Immunotherapy - ScienceDirect
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
Natalizumab treatment of multiple sclerosis: new insights | Immunotherapy
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR) - Sabol - 2017 - Cancer Medicine - Wiley Online Library
Emerging Therapies for Progressive Multiple Sclerosis - Practical Neurology
Natalizumab - Wikipedia
Natalizumab (Tysabri). - Abstract - Europe PMC
Natalizumab - Wikipedia
Treating Multiple Sclerosis With Monoclonal Antibodies
Potential mechanisms of action related to the efficacy and safety of cladribine - Multiple Sclerosis and Related Disorders
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities
